Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 21, 2013 03:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Presents Vitaros(R) Poster at the International Symposium on Prostate, Androgens and Men's Sexual Health

SAN DIEGO, June 21, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that it will present a poster with results of...
June 10, 2013 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction

SAN DIEGO, June 10, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), today announced that its marketing application for...
May 23, 2013 09:15 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Prices $17.1 Million Public Offering of Common Stock and Warrants

SAN DIEGO, May 23, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) today announced that it has priced an underwritten public offering of an aggregate...
May 22, 2013 16:01 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Proposed Public Offering of Common Stock and Warrants

SAN DIEGO, May 22, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) today announced that it intends to offer shares of common stock and warrants in an...
May 10, 2013 08:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Provides First Quarter 2013 Corporate Update

SAN DIEGO, May 10, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), today provided an update regarding ongoing corporate...
May 07, 2013 14:31 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call

SAN DIEGO, Calif., May 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that it will hold a conference call to...
May 07, 2013 11:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Poster Presentation of Vitaros(R) Data in Men Previously Unresponsive to PDE-5 Inhibitors at American Urological Association Annual Meeting

SAN DIEGO, May 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that John P. Mulhall, MD, Director of the Male...
April 18, 2013 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at 2013 BIO International Convention

SAN DIEGO, April 18, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that Edward Cox, Vice President Corporate...
April 01, 2013 16:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Sale of Non-Core Assets

SAN DIEGO, April 1, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) today announced the sale of (1) Totect® (dexrazoxane...
March 18, 2013 11:15 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Provides Corporate Update; Files Annual Report for Quarter and Year Ended December 31, 2012

SAN DIEGO, March 18, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), today provided an update regarding ongoing corporate...